Bicarbonate

Bicarbonate

SCHEMBL641446

C.CC.O=C(O)O.O=C(O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.62
CA2 P00918 1/20 0.62
CA9 Q16790 1/20 0.62
FFAR3 O14843 3/20 0.50
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
LMNA P02545 3/20 0.40
TSHR P16473 3/20 0.36
ACHE P22303 1/20 0.36
THPO P40225 1/20 0.36
TP53 P04637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
LDHA P00338 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL12489460 1.00 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL11280337 0.94
Bicarbonate SCHEMBL27082179 0.94 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL28577539 0.94 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL29181726 0.94 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL47980 0.94 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL2890152 0.88 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL28358443 0.88 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL5082549 0.88 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL28623473 0.88 CA1 (0.62) CA1CA2CA9FFAR3LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11817545-B2 Secondary electrochemical cells with separator and electrolyte combination DURACELL U.S. OPERATIONS, INC. (US) 2023-11-14 US claimed
EP-3645655-B1 POLYMER LIQUID COMPOSITES FOR IMPROVED ANTI-FOULING PERFORMANCE HRL LAB LLC (US) 2023-09-27 EP claimed
CN-111655791-B Pest and ice phobic compositions with fluid additives HRL实验室有限责任公司 2022-11-04 CN claimed
CN-110799619-B Polymer-liquid composites for improved antifouling properties HRL实验室有限责任公司 2022-04-26 CN claimed
US-20210367262-A1 SECONDARY ELECTROCHEMICAL CELLS WITH SEPARATOR AND ELECTROLYTE COMBINATION DURACELL U.S. OPERATIONS, INC. (US) 2021-11-25 US claimed
EP-3526295-B1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH LIQUID ADDITIVES HRL LAB LLC (US) 2021-08-04 EP claimed
US-11081721-B2 Secondary electrochemical cells with separator and electrolyte combination DURACELL U.S. OPERATIONS, INC. (US) 2021-08-03 US claimed
US-11072713-B2 Bugphobic and icephobic compositions with fluid additives HRL LABORATORIES, LLC (US) 2021-07-27 US claimed
US-11034846-B2 Polymer-liquid composites for improved anti-fouling performance HRL LABORATORIES, LLC (US) 2021-06-15 US claimed
CN-109804029-B Pest and ice phobic compositions with liquid additives HRL实验室有限责任公司 2021-05-25 CN claimed
EP-3526295-A1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH LIQUID ADDITIVES HRL Laboratories, LLC (US) 2019-08-21 EP claimed
WO-2019152081-A1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES HRL LABORATORIES, LLC (US) 2019-08-08 WO claimed
US-20190023910-A1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES HRL LABORATORIES, LLC 2019-01-24 US claimed
WO-2019005272-A1 POLYMER–LIQUID COMPOSITES FOR IMPROVED ANTI-FOULING PERFORMANCE HRL LABORATORIES, LLC (US) 2019-01-03 WO claimed
US-20180237643-A1 POLYMER-LIQUID COMPOSITES FOR IMPROVED ANTI-FOULING PERFORMANCE HRL LABORATORIES, LLC 2018-08-23 US claimed
WO-2018071349-A1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH LIQUID ADDITIVES HRL LABORATORIES, LLC (US) 2018-04-19 WO claimed
US-20180030329-A1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH LIQUID ADDITIVES HRL LABORATORIES, LLC 2018-02-01 US claimed
US-20160351942-A9 SECONDARY ELECTROCHEMICAL CELLS WITH SEPARATOR AND ELECTROLYTE COMBINATION DURACELL U.S. OPERATIONS, INC. (US) 2016-12-01 US claimed
WO-2013180923-A1 SECONDARY ELECTROCHEMICAL CELLS WITH SEPARATOR AND ELECTROLYTE COMBINATION THE GILLETTE COMPANY (US) 2013-12-05 WO claimed
US-20130323607-A1 SECONDARY ELECTROCHEMICAL CELLS WITH SEPARATOR AND ELECTROLYTE COMBINATION ISSAEV NIKOLAI NIKOLAEVICH (US) 2013-12-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11072713-B2 Bugphobic and icephobic compositions with fluid additives FUS, IGF2BP1, IGF2BP3 CA1 1418/4885CA2 1690/4885CA9 3032/4885
US-20180030329-A1 BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH LIQUID ADDITIVES SLC14A1, MYB, FUS CA1 1052/4885CA2 1264/4885CA9 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.